"10.1371_journal.pone.0045047","plos one","2012-09-20T00:00:00Z","Alexandra Canonici; Emilie Pellegrino; Carole Siret; Chloé Terciolo; Dorota Czerucka; Sonia Bastonero; Jacques Marvaldi; Dominique Lombardo; Véronique Rigot; Frédéric André","Aix-Marseille Université, Centre de Recherche en Oncologie et Oncopharmacologie, Marseille, France; Inserm UMR 9111, Marseille, France; Team 4, Inflammation, Cancer, Cancer Stem Cells, INSERM U895, Centre Méditerranéen de Médecine Moléculaire, Nice, France","Conceived and designed the experiments: FA VR DL. Performed the experiments: AC EP CS DC CT. Analyzed the data: FA VR SB EP AC DL JM. Contributed reagents/materials/analysis tools: DC. Wrote the paper: FA.","D. Czerucka has acted as a consultant or scientific advisor to the company interested in developing therapeutic interventions for intestinal infections and inflammatory disorders; this company is BIOCODEX S.A. (Gentilly, France). She has financial competing interests, including salaries and travel grant. The content of this article was neither influenced nor constrained by this fact. Co-author Frédéric André is a PLOS ONE Editorial Board member. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","09","Alexandra Canonici","AC",10,TRUE,3,5,7,1,TRUE,TRUE,FALSE,0,NA,FALSE
